Saturday, June 4, 2022
- 5:30pm-7:00pm
-
Longitudinal Mortality Risks and Renal Functional Outcomes in Living Kidney Donors
Kidney Living Donor: Long Term Outcomes • Hynes Halls C & D
- 5:30pm-7:00pm
-
Low-Dose Aspirin is More Critical Than Statins in Preventing Transplant Renal Artery Stenosis
Kidney: Cardiovascular and Metabolic Complications • Hynes Halls C & D
- 5:30pm-7:00pm
-
Low-Quality Kidney Allograft Use in Kidney Transplantation is Associated with a Prolonged Post-Transplant Length of Stay
Kidney Deceased Donor Allocation • Hynes Halls C & D
- 5:30pm-7:00pm
-
Lucas Device Assisted Uncontrolled Dcd Kidney Transplantation – A Feasible but Underutilized Option in the United States
Kidney Deceased Donor Selection • Hynes Halls C & D
- 5:30pm-7:00pm
-
MELD -Na 15 and Lower – Way to Go Forward- DCD Liver Transplant or Wait for a Higher MELD Score ?
Liver: Expanding the Donor Pool* (Liver: MELD Allocation / Donor Issues) • Hynes Halls C & D
- 5:30pm-7:00pm
-
Modification of Gut Microbiota Accelerates Kidney Repair After Experimental Ischemia Reperfusion Injury
Ischemia Reperfusion • Hynes Halls C & D
- 5:30pm-7:00pm
-
Mortality and Cardiovascular Outcomes in Adult Non-Liver Solid Organ Transplant Patients with Non-Alcoholic Steatohepatitis
Liver: Retransplantation and Other Complications • Hynes Halls C & D
- 5:30pm-7:00pm
-
National Attitudes Towards Early Liver Transplantation for Alcoholic Liver Disease
Liver: Recipient Selection • Hynes Halls C & D
- 5:30pm-7:00pm
-
National Landscape of the Utilization of Living Donor Liver Allografts in Redo Liver Transplantation
Liver: Recipient Selection • Hynes Halls C & D
- 5:30pm-7:00pm
-
National Survey of Solid Organ Transplant Pharmacist Training and Early Career Research Success
Quality Assurance Process Improvement & Regulatory Issues • Hynes Halls C & D
- «Previous Page
- 1
- …
- 18
- 19
- 20
- 21
- 22
- …
- 33
- Next Page»